Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography

Wenjuan SONG; Xuejuan MA; Yue SUN; Ying GU; Yujia YE; Shumo LI; Fei GE; Liping LIU; Yue ZHAO; Yu WANG

doi:10.12259/j.issn.2095-610X.S20230217

Volume 44 Issue 2

Feb. 2023

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2023 > 44(2): 108-112

Wenjuan SONG, Xuejuan MA, Yue SUN, Ying GU, Yujia YE, Shumo LI, Fei GE, Liping LIU, Yue ZHAO, Yu WANG. Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography[J]. Journal of Kunming Medical University, 2023, 44(2): 108-112. doi: 10.12259/j.issn.2095-610X.S20230217

Citation:

Wenjuan SONG, Xuejuan MA, Yue SUN, Ying GU, Yujia YE, Shumo LI, Fei GE, Liping LIU, Yue ZHAO, Yu WANG. Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography[J]. Journal of Kunming Medical University, 2023, 44(2): 108-112. doi: 10.12259/j.issn.2095-610X.S20230217

Citation:

Wenjuan SONG, Xuejuan MA, Yue SUN, Ying GU, Yujia YE, Shumo LI, Fei GE, Liping LIU, Yue ZHAO, Yu WANG. Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography[J]. Journal of Kunming Medical University, 2023, 44(2): 108-112. doi: 10.12259/j.issn.2095-610X.S20230217

PDF( 606 KB)

Evaluation of Cardiotoxicity in Trastuzumab Treatment of Breast Cancer Using Three-dimensional Speckle Tracking Echocardiography

doi: 10.12259/j.issn.2095-610X.S20230217

1.
Dept. of Cardiology，The First Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032
2.
Dept. of Breast Surgery，The First Affiliated Hospital of Kunming Medical University，Kunming Yunnan 650032 ，China

Received Date: 2022-12-14
Available Online: 2023-02-01
Publish Date: 2023-02-25

Abstract

Abstract

Objective To investigate the application of three-dimensional speck tracking echocardiography in the evaluation of cardiotoxicity in trastuzumab treatment of breast cancer. Methods A total of 65 breast cancer patients treated with trastuzumab in the First Affiliated Hospital of Kunming Medical University from November 2020 to July 2022 were selected. Conventional echocardiography and three-dimensional speckle tracking technique （3D-STI） were performed 3, 6, 9, and 12 months after treatment. The differences in cardiac parameters at different time points were observed. The parameters included left ventricular ejection fraction （LVEF）, left atrial volume index （LAVI）, early diastolic mitral flow velocity/early diastolic mitral annular flow velocity （E/Em）, early diastolic mitral annular flow velocity/late diastolic mitral annular flow velocity （Em/Am）, early diastolic mitral annular flow velocity （Sm）, and early diastolic mitral annular flow velocity （E/Em）. Peak E）, peak late diastolic mitral flow velocity （peak A）, early diastolic mitral annular velocity （Em）, late diastolic mitral annular velocity （Am）, left ventricular torsion （LVtw）, global longitudinal strain （GLS）, global circumferential strain （GCS）, global radial strain （GRS）, global area strain （GAS）. Results Compared with those before treatment, LAVI, E/Em and Am increased 3 months, 6 months, 9 months, and 12 months after treatment, while Em/Am and Em decreased. LAVI and E/Em were positively correlated. Compared with before and after treatment, LVEF, GLS, GRS, LVtw, GCS and GAS decreased 3, 6, 9 and 12 months after treatment （P < 0.05）. Conclusions The application of three-dimensional echocardiographic speck tracking technology in the treatment of breast cancer patients with trastuzumab has an ideal effect, which can judge the cardiotoxicity more early and accurately, provide a reference for early treatment, and has value in improving prognosis and clinical outcome.
- Echocardiography,
- Three-dimensional speckle tracking technology,
- Breast cancer,
- Trastuzumab,
- Cardiotoxicity,
- Assessment

FullText(HTML)

References(20)

References

[1]	孙文婧,胡曼婷,李娜,葛菲,陈文林,刘洋. 乳腺癌内分泌治疗耐药及其逆转的研究进展[J]. 昆明医科大学学报,2021,42(07):143-149.
[2]	刘安生,魏虹,商志娟,等. 超声心动图评估化疗药物对乳腺癌患者左心房结构,机械功能和机械离散度的影响[J]. 中国循环杂志,2020,35(12):1212-1215. doi: 10.3969/j.issn.1000-3614.2020.12.009
[3]	Gripp E A,Oliveira G E,Feijó L A,et al. Global longitudinal strain accuracy for cardiotoxicity prediction in a cohort of breast cancer patients during anthracycline and/or trastuzumab treatment[J]. Arquivos brasileiros de cardiologia,2018,110:140-150.
[4]	Puckett L L,Saba S G,Henry S,et al. Cardiotoxicity screening of long‐term,breast cancer survivors—The CAROLE (Cardiac‐Related Oncologic Late Effects) Study[J]. Cancer medicine,2021,10(15):5051-5061. doi: 10.1002/cam4.4037
[5]	Timóteo A T,Moura Branco L,Filipe F,et al. Cardiotoxicity in breast cancer treatment: what about left ventricular diastolic function and left atrial function?[J]. Echocardiography,2019,36(10):1806-1813. doi: 10.1111/echo.14487
[6]	蒋瑶,牟霜,谭开彬. 二维斑点追踪成像评价乳腺癌曲妥珠单抗化疗亚临床心脏毒性的价值[J]. 临床超声医学杂志,2020,22(1):33-37. doi: 10.3969/j.issn.1008-6978.2020.01.012
[7]	Anthony F Y,Ho A Y,Braunstein L Z,et al. Assessment of early radiation-induced changes in left ventricular function by myocardial strain imaging after breast radiation therapy[J]. Journal of the American Society of Echocardiography,2019,32(4):521-528. doi: 10.1016/j.echo.2018.12.009
[8]	Gulati G,Zhang K W,Scherrer-Crosbie M,et al. Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab[J]. Current Heart Failure Reports,2014,11(4):366-373. doi: 10.1007/s11897-014-0214-8
[9]	Bouwer N I,Jager A,Liesting C,et al. Cardiac monitoring in HER2-positive patients on trastuzumab treatment:A review and implications for clinical practice[J]. The Breast,2020,52:33-44. doi: 10.1016/j.breast.2020.04.005
[10]	Chen J,Wang L,Wu F F,et al. Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy[J]. Echocardiography,2019,36(9):1682-1688. doi: 10.1111/echo.14467
[11]	Chang W T,Feng Y H,Kuo Y H,et al. Layer-specific distribution of myocardial deformation from anthracycline-induced cardiotoxicity in patients with breast cancer—from bedside to bench[J]. International Journal of Cardiology,2020,311:64-70. doi: 10.1016/j.ijcard.2020.01.036
[12]	Abu-Khalaf M M,Safonov A,Stratton J,et al. Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy[J]. Breast Cancer Research and Treatment,2019,176(2):261-270. doi: 10.1007/s10549-019-05178-z
[13]	董百惠,姜红,肖响,等. 乳腺癌患者蒽环类续贯曲妥珠单抗治疗期间超声心动图监测执行度分析[J]. 中国药物警戒,2022,19(5):557-560.
[14]	刘志月,刘梅,黄鹤,等. 实时三维超声心动图及三维斑点追踪技术评估左心室射血分数保留的多发性骨髓瘤患者左心房功能的价值[J]. 临床心血管病杂志,2021,37(10):936-942.
[15]	胡夕春,张剑,陈德滇,等. 中国蒽环类药物治疗乳腺癌专家共识[J]. 中国肿瘤临床,2018,45(3):120-125. doi: 10.3969/j.issn.1000-8179.2018.03.198
[16]	李捷,郭冠军,杨益宁,等. 三维斑点追踪超声心动图对老年心力衰竭患者左心室舒张功能的评估价值[J]. 中国医师杂志,2021,23(11):1673-1676. doi: 10.3760/cma.j.cn431274-20200906-01237
[17]	Kosku H,Kaya C T,Sengul S,et al. The diastolic function abnormalities in hemodialysis session: a two-dimensional speckle tracking echocardiographic (2DSTE) study[J]. The International Journal of Cardiovascular Imaging,2022,38(7):1453-1461. doi: 10.1007/s10554-022-02535-w
[18]	Ebik M,Tatekin N,M Gürdoan,et al. fri0058 the importancn of speckle trackizg echocardiography in the evaluation of cardiac functions in patients with rheumatoid arthritis[J]. Annals of the Rheumatic Diseases,2020,79(1):605-606.
[19]	胡滨,礼广森,黄冬梅,等. 三维斑点追踪技术评价含曲妥珠单抗化疗方案对HER-2阳性乳腺癌患者左室功能的影响[J]. 临床超声医学杂志,2020,22(8):622-625. doi: 10.3969/j.issn.1008-6978.2020.08.021
[20]	杜晓,袁莉. 实时三维斑点追踪技术在中老年急性心肌梗死患者经皮冠状动脉介入治疗术后左心室整体收缩功能评估中的应用价值[J]. 中国药物与临床,2020,20(8):1245-1247.

Relative Articles(20)

Relative Articles

[1]	Zheng ZHANG, Yanhong YANG, Zaihui FENG, Lujiang ZHAN, Jinxian PU, Qianting DUAN. Value of High Field Tntensity MRIT1 Perfusion Imaging Combined with DWI Imaging in Evaluating The Efficacy of Neoadjuvant Chemotherapy for Breast Cancer. Journal of Kunming Medical University, 2024, 45(7): 148-153. doi: 10.12259/j.issn.2095-610X.S20240722
[2]	Xuemei CHEN, Pin GUO, Liufang CHUAN, Zi WANG, Xuejiao LI, Wenji HE. Evaluation of Cardiac Toxicity of Anthracyclines in Children with Acute Leukemia Based on Tei Index. Journal of Kunming Medical University, 2024, 45(2): 117-122. doi: 10.12259/j.issn.2095-610X.S20240216
[3]	Shuishui PAN, Jinsong BAI, Chongxi LI, Zhiqiong AI, Bo TIAN, Changlei MU, Yihan LIU, Jun LIU. Influencing Factors of Echocardiographic Abnormalities in HIV/AIDS Patients. Journal of Kunming Medical University, 2023, 44(4): 148-153. doi: 10.12259/j.issn.2095-610X.S20230422
[4]	Linkun TA, Yanling HUANG, Jingqiu ZhANG, Yongping LU. Value of Different Sections of Echocardiography in the Diagnosis of Fetal Congenital Vascular Ring. Journal of Kunming Medical University, 2022, 43(6): 79-84. doi: 10.12259/j.issn.2095-610X.S20220615
[5]	Wen-jing SUN, Man-ting HU, Na LI, Fei GE, Wen-lin CHEN, Yang LIU. Progress in Clinical Research on Drug Resistance and Reversal of Endocrine Therapy in Breast Cancer. Journal of Kunming Medical University, 2021, 42(7): 143-149. doi: 10.12259/j.issn.2095-610X.S20210724
[6]	Juan ZHAO, Teng-can TU, Mei-jun YANG, Xiao-yong ZHANG, Wei PAN. Assessment of Early Coronary Artery Disease in Patients with Acute Coronary Syndrome. Journal of Kunming Medical University, 2021, 42(12): 47-50. doi: 10.12259/j.issn.2095-610X.S20211219
[7]	Li-zheng WEI, Jie-qing MIN, Jin-run TIAN, Yan-jie CAO, Peng PAN, Peng WANG, Yun-juan YANG, Yun-jiao LUO. The Characteristics of Echocardiography in Acute Incomplete Kawasaki Disease among Infants and Young Children in Yunnan Province. Journal of Kunming Medical University, 2021, 42(9): 114-118. doi: 10.12259/j.issn.2095-610X.S20210923
[8]	Lin-kun TA, Yan-ling HUANG, Yong-ping LU. The Value of Echocardiography in Diagnosing Fetal Tetralogy of Fallot. Journal of Kunming Medical University, 2021, 42(1): 142-146. doi: 10.12259/j.issn.2095-610X.S20210126
[9]	Li Ning , Xu Miao , Zhang Wei , Zhang Qing , Kong Ying . Clinical Significance of Serum Vitamin D Levels Change in Patients with Breast Cancer before and after Chemoradiotherapy. Journal of Kunming Medical University, 2018, 39(08): 108-112.
[10]	Ye Xue Qun , Nie Lei . . Journal of Kunming Medical University, 2017, 38(02): 95-98.
[11]	Wang Yi Ming , Yang Yue . Comparison of the Diagnosis Significance for Breast Cancer between Single High Frequency Ultrasonography and Mammography. Journal of Kunming Medical University, 2017, 38(06): 48-51.
[12]	Guo Xue Jun , Miao Chun Mei , Tang Qing Wen , Jin Xue Mei , Yang Yue . Clinical Study on Thyroid Space Occupying Lesion by Ultrasound in Patients with Breast Cancer. Journal of Kunming Medical University, 2016, 37(11): 86-88.
[13]	Li Yun Fen . . Journal of Kunming Medical University,
[14]	Li Xiao Yong . . Journal of Kunming Medical University,
[15]	Zhao Chun Fang . . Journal of Kunming Medical University, 2013, 34(01): 1-1.
[16]	He Guang Lin . . Journal of Kunming Medical University,
[17]	Han Jiang Qiong . . Journal of Kunming Medical University,
[18]	Chen Xian Yu . . Journal of Kunming Medical University,
[19]	Wu An Yue. . Journal of Kunming Medical University,
[20]	Li Kun Lun . Effect of Survivin Gene Expression Inhibition by RNAi on Breast Cancer SKBr-3 Cells. Journal of Kunming Medical University,